<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; apprehensive</title>
	<atom:link href="http://www.tapanray.in/tag/apprehensive/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Pharma: Experts’ Handholding is Pivotal in Digital Marketing Transition Phase</title>
		<link>http://www.tapanray.in/pharma-experts-handholding-is-pivotal-in-digital-marketing-transition-phase/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pharma-experts-handholding-is-pivotal-in-digital-marketing-transition-phase</link>
		<comments>http://www.tapanray.in/pharma-experts-handholding-is-pivotal-in-digital-marketing-transition-phase/#comments</comments>
		<pubDate>Mon, 14 Jan 2019 00:00:28 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[applications]]></category>
		<category><![CDATA[apprehension]]></category>
		<category><![CDATA[apprehensive]]></category>
		<category><![CDATA[apps]]></category>
		<category><![CDATA[commence]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[Enterprise]]></category>
		<category><![CDATA[ERP]]></category>
		<category><![CDATA[expert]]></category>
		<category><![CDATA[Handholding]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[Planning]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Resource]]></category>
		<category><![CDATA[software]]></category>
		<category><![CDATA[start]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[tools]]></category>
		<category><![CDATA[transition]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9362</guid>
		<description><![CDATA[&#8220;Pilman – A Tapan Ray Website on Helathcare&#8221; completes 10 years, today.  Inspired by some of my dear friends, I created this website on January 14, 2009. Since then, reasonably well-researched articles, penned by me, on various aspects of health &#8230; <a href="http://www.tapanray.in/pharma-experts-handholding-is-pivotal-in-digital-marketing-transition-phase/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/pharma-experts-handholding-is-pivotal-in-digital-marketing-transition-phase/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Patented Drugs’ Pricing: Apprehensive Voices Could Turn into a Self-Defeating Prophecy</title>
		<link>http://www.tapanray.in/patented-drugs-pricing-apprehensive-voices-could-turn-into-a-self-defeating-prophecy/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=patented-drugs-pricing-apprehensive-voices-could-turn-into-a-self-defeating-prophecy</link>
		<comments>http://www.tapanray.in/patented-drugs-pricing-apprehensive-voices-could-turn-into-a-self-defeating-prophecy/#comments</comments>
		<pubDate>Mon, 04 Mar 2013 00:00:15 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[apprehensive]]></category>
		<category><![CDATA[approval]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[capita]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[CIPI]]></category>
		<category><![CDATA[Committee]]></category>
		<category><![CDATA[DIPP]]></category>
		<category><![CDATA[DoP]]></category>
		<category><![CDATA[FICCI]]></category>
		<category><![CDATA[FOPE]]></category>
		<category><![CDATA[gandhi]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[IDMA]]></category>
		<category><![CDATA[IIT]]></category>
		<category><![CDATA[income]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Intellectual]]></category>
		<category><![CDATA[IPA]]></category>
		<category><![CDATA[Kharagpur]]></category>
		<category><![CDATA[Law]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[MSF]]></category>
		<category><![CDATA[negotiation]]></category>
		<category><![CDATA[NewZealand]]></category>
		<category><![CDATA[NGO]]></category>
		<category><![CDATA[NPPA]]></category>
		<category><![CDATA[OPPI]]></category>
		<category><![CDATA[parity]]></category>
		<category><![CDATA[patented]]></category>
		<category><![CDATA[PCPD]]></category>
		<category><![CDATA[per]]></category>
		<category><![CDATA[power]]></category>
		<category><![CDATA[Pricing]]></category>
		<category><![CDATA[products]]></category>
		<category><![CDATA[Property]]></category>
		<category><![CDATA[purchasing]]></category>
		<category><![CDATA[rajiv]]></category>
		<category><![CDATA[ratio]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Report]]></category>
		<category><![CDATA[support]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[UK]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=2016</guid>
		<description><![CDATA[On February 21, 2013, the Department of Pharmaceuticals in a communication to the stakeholders announced that the committee to examine the issues of ‘Price Negotiations for Patented Drugs’ has since submitted its report to the Department. Simultaneously the stakeholders were &#8230; <a href="http://www.tapanray.in/patented-drugs-pricing-apprehensive-voices-could-turn-into-a-self-defeating-prophecy/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/patented-drugs-pricing-apprehensive-voices-could-turn-into-a-self-defeating-prophecy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Growing menace of counterfeit drugs in India: why is the domestic pharmaceutical industry still so apprehensive with the new Amendments of the ACT?</title>
		<link>http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2</link>
		<comments>http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/#comments</comments>
		<pubDate>Wed, 29 Apr 2009 00:30:15 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[Amendments]]></category>
		<category><![CDATA[apprehensive]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[domestic]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Growing]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[so]]></category>
		<category><![CDATA[still]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[why]]></category>
		<category><![CDATA[with]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=903</guid>
		<description><![CDATA[The growing menace of Counterfeit drugs has remained a serious threat to the healthcare space of India. Do we have any credible data to assess the magnitude of this menace in India? No we do not have, as yet. At &#8230; <a href="http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
